仿形(计算机编程)
计算生物学
生物
可塑性
计算机科学
物理
热力学
操作系统
作者
Esther Redín,Álvaro Quintanal-Villalonga,Charles M. Rudin
标识
DOI:10.1016/j.trecan.2024.07.008
摘要
Small cell lung cancer (SCLC) is a devastating disease with high proliferative and metastatic capacity. SCLC has been classified into molecular subtypes based on differential expression of lineage-defining transcription factors. Recent studies have proposed new subtypes that are based on both tumor-intrinsic and -extrinsic factors. SCLC demonstrates substantial intratumoral subtype heterogeneity characterized by highly plastic transcriptional states, indicating that the initially dominant subtype can shift during disease progression and in association with resistance to therapy. Strategies to promote or constrain plasticity and cell fate transitions have nominated novel targets that could prompt the development of more durably effective therapies for patients with SCLC. In this review, we describe the latest advances in SCLC subtype classification and their biological and clinical implications.
科研通智能强力驱动
Strongly Powered by AbleSci AI